chr14-64227477-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000353772.7(ESR2):c.*56G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.579 in 1,567,086 control chromosomes in the GnomAD database, including 268,171 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 34506 hom., cov: 33)
Exomes 𝑓: 0.57 ( 233665 hom. )
Consequence
ESR2
ENST00000353772.7 3_prime_UTR
ENST00000353772.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.441
Publications
56 publications found
Genes affected
ESR2 (HGNC:3468): (estrogen receptor 2) This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
ESR2 Gene-Disease associations (from GenCC):
- male infertility with azoospermia or oligozoospermia due to single gene mutationInheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center
- familial medullary thyroid carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ovarian dysgenesis 8Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 14-64227477-C-T is Benign according to our data. Variant chr14-64227477-C-T is described in ClinVar as Benign. ClinVar VariationId is 1286246.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.872 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ESR2 | NR_073496.2 | n.2211G>A | non_coding_transcript_exon_variant | Exon 8 of 8 | ||||
| ESR2 | NM_001040275.1 | c.*56G>A | 3_prime_UTR_variant | Exon 9 of 9 | NP_001035365.1 | |||
| ESR2 | NM_001291712.2 | c.*56G>A | 3_prime_UTR_variant | Exon 14 of 14 | NP_001278641.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ESR2 | ENST00000353772.7 | c.*56G>A | 3_prime_UTR_variant | Exon 9 of 9 | 1 | ENSP00000335551.4 | ||||
| ESR2 | ENST00000554572.5 | c.*56G>A | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000450699.1 | ||||
| ESR2 | ENST00000555278.5 | c.*413G>A | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000450488.1 |
Frequencies
GnomAD3 genomes AF: 0.658 AC: 100031AN: 152048Hom.: 34453 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
100031
AN:
152048
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.571 AC: 807400AN: 1414920Hom.: 233665 Cov.: 22 AF XY: 0.568 AC XY: 400773AN XY: 705992 show subpopulations
GnomAD4 exome
AF:
AC:
807400
AN:
1414920
Hom.:
Cov.:
22
AF XY:
AC XY:
400773
AN XY:
705992
show subpopulations
African (AFR)
AF:
AC:
28611
AN:
32090
American (AMR)
AF:
AC:
22704
AN:
42726
Ashkenazi Jewish (ASJ)
AF:
AC:
16461
AN:
25650
East Asian (EAS)
AF:
AC:
25283
AN:
39380
South Asian (SAS)
AF:
AC:
41736
AN:
83292
European-Finnish (FIN)
AF:
AC:
29821
AN:
53212
Middle Eastern (MID)
AF:
AC:
3358
AN:
5654
European-Non Finnish (NFE)
AF:
AC:
604446
AN:
1074154
Other (OTH)
AF:
AC:
34980
AN:
58762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
16741
33483
50224
66966
83707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16760
33520
50280
67040
83800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.658 AC: 100139AN: 152166Hom.: 34506 Cov.: 33 AF XY: 0.653 AC XY: 48608AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
100139
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
48608
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
36544
AN:
41536
American (AMR)
AF:
AC:
8574
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2223
AN:
3470
East Asian (EAS)
AF:
AC:
3594
AN:
5180
South Asian (SAS)
AF:
AC:
2435
AN:
4826
European-Finnish (FIN)
AF:
AC:
6056
AN:
10564
Middle Eastern (MID)
AF:
AC:
163
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38491
AN:
67984
Other (OTH)
AF:
AC:
1347
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1631
3262
4894
6525
8156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2127
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.